©2019 by Foundation Venture Capital Group

OUR PORTFOLIO OF COMPANIES

Good Science Makes Good Business™

 

Actinobac is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Drug candidates are based upon Leukothera® (LtxA), a natural protein that targets and eliminates white blood cells (WBCs) involved in the mechanism of many diseases.